XBiotech Inc (XBIT) — Cash Flow Reinvestment Rate

Latest as of December 2022: 1.45x

XBiotech Inc (XBIT) has a Cash Flow Reinvestment Rate of 1.45x as of December 2022, reinvesting $3.91 Million (capex $132.00K plus investments $-3.77 Million) from operating cash flow of $2.70 Million. Check how high is XBiotech Inc's earnings quality to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

1.45x
(Capex + Investments) / Operating CF

Total Reinvested

$3.91 Million
Capex + Investments

Operating Cash Flow

$2.70 Million
USD

Capital Expenditures

$132.00K
USD

XBiotech Inc Cash Flow Reinvestment Rate (2021–2021)

Historical reinvestment intensity for XBiotech Inc across 1 annual periods. Explore XBiotech Inc (XBIT) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Annual Cash Flow Reinvestment Rate for XBiotech Inc (2021–2021)

Year-by-year capital reinvestment analysis for XBiotech Inc. For live market cap and broader valuation context, see XBiotech Inc market capitalisation.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2021 0.10x $7.05 Million $69.44 Million $3.52 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow